Clinicians must also be cognizant of those likely to be at increased risk for early recurrence and aggressive tumor behavior, that is, patients who have undergone subtotal tumor resections or biopsies, tumors with Ki-67 indices of 5% or more and/or high mitotic rates, and older age at presentation (i.e., >40 years). This evidence concerns the gene MKI67 and neoplasm.